While the coronavirus outbreak has brought new attention to the importance of innovative cross-stakeholder partnerships, the biopharmaceutical industry has a long history of collaborative efforts. Together, these collaborations and partnerships work to deliver new treatments and potential cures to patients. A new PhRMA report provides a look at the various collaborative partnerships currently taking place across the research ecosystem and healthcare system, including those addressing the pandemic.